Germany· DE-A57-92f3118d49ac78d1
Alk-Prick N
A medicinal product containing ambrosia artemisiifolia (302), registered in Germany by Alk-Abelló Arzneimittel Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ambrosia Artemisiifolia (302)
- Manufacturer
- Alk-Abelló Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ambrosia artemisiifolia (302) in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandPrick-Test Ambrosia artemisiifolia, PricktestlösungDermapharm AG
- United StatesAmbrosia artemisiaefoliaBoiron
- United KingdomShort Ragweed (Ambrosia artemisiifolia) pollen 50,000BU/ml solution for skin prick testAllergopharma
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Ragwizax
- Bulgaria · Алиостал Прик, Алергенен Екстракт От Полени От Плевели, Рагвизакс
- Czechia · Ragwizax
- France · Ragwizax
- Croatia · Ragwizax
- Hungary · Alyostal Prick Pollenek, Lais Ragweed I
- Romania · Ragwizax
- Slovenia · Ragwizax
- Slovakia · Ragwizax, Soluprick
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ebfbc5dd-6565-4dd3-be5f-5fdbd8b8030d GET /v1/drugs/ebfbc5dd-6565-4dd3-be5f-5fdbd8b8030d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ambrosia Artemisiifolia (302)",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ambrosia artemisiifolia (302).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.